Lonza | LONN - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Akzo Nobel EUR 2.76B 1.14B 2026-03
Alcon AG USD 1.58B 80M 2026-03
Almirall EUR 337.77M 14.83M 2025-12
AstraZeneca USD 4.89B 2.67B 2026-06
BASF EUR 7.8B 4.71B 2026-06
Bayer EUR 5.73B 943M 2026-03
Beiersdorf EUR 1.2B 33M 2025-12
Covestro EUR 648M 44M 2025-12
Demant DKK 1.33B 188M 2025-12
Fresenius EUR 2.06B 752M 2026-03
Fresenius Medical Care EUR 1.24B 343.37M 2026-03
Geberit CHF 403.6M 4.1M 2025-03
Genmab DKK 1.72B 46M 2025-12
Givaudan CHF 603M 3M 2024-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
GN Store Nord DKK 1.12B 352M 2025-12
Hikma Pharmaceutical USD 217M 19M 2025-12
Johnson Matthey GBP 542M 49M 2024-06
Merck EUR 2.74B 415M 2026-03
Novartis USD 7.62B 739M 2026-06
Philips EUR 1.79B 803M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 6.35B 806M 2026-06
Sika AG CHF 1.87B 1.18B 2022-12
Solvay EUR 367M 119M 2026-06
UCB EUR 1.57B 1.14B 2024-12